Lazard Asset Management’s Vir Biotechnology VIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,799
| Closed | -$16K | – | 2501 |
|
|
2023
Q3 | $16K | Buy |
1,799
+542
| +43% | +$4.82K | ﹤0.01% | 2124 |
|
|
2023
Q2 | $30K | Sell |
1,257
-3,314
| -73% | -$79.1K | ﹤0.01% | 2004 |
|
|
2023
Q1 | $106K | Buy |
4,571
+214
| +5% | +$4.96K | ﹤0.01% | 1512 |
|
|
2022
Q4 | $110K | Buy |
+4,357
| New | +$110K | ﹤0.01% | 1496 |
|
|
2022
Q3 | – | Sell |
-3,943
| Closed | -$100K | – | 2583 |
|
|
2022
Q2 | $100K | Buy |
3,943
+280
| +8% | +$7.1K | ﹤0.01% | 1508 |
|
|
2022
Q1 | $94K | Buy |
3,663
+3,631
| +11,347% | +$93.2K | ﹤0.01% | 1421 |
|
|
2021
Q4 | $1K | Sell |
32
-1,218
| -97% | -$38.1K | ﹤0.01% | 2259 |
|
|
2021
Q3 | $54K | Buy |
+1,250
| New | +$54K | ﹤0.01% | 1656 |
|
|
2020
Q4 | – | Sell |
-242
| Closed | -$8K | – | 2000 |
|
|
2020
Q3 | $8K | Buy |
+242
| New | +$8K | ﹤0.01% | 1505 |
|